

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 6.47110866 |
| 2 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.62760113 |
| 3 | epithelial cilium movement (GO:0003351) | 4.61202913 |
| 4 | axoneme assembly (GO:0035082) | 4.55265118 |
| 5 | cilium movement (GO:0003341) | 4.42458112 |
| 6 | regulation of cilium movement (GO:0003352) | 4.42027012 |
| 7 | axonemal dynein complex assembly (GO:0070286) | 4.27819773 |
| 8 | presynaptic membrane assembly (GO:0097105) | 4.18228231 |
| 9 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.10368008 |
| 10 | superoxide anion generation (GO:0042554) | 3.97298161 |
| 11 | presynaptic membrane organization (GO:0097090) | 3.93292048 |
| 12 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.86955505 |
| 13 | regulation of microtubule-based movement (GO:0060632) | 3.75602341 |
| 14 | startle response (GO:0001964) | 3.50941368 |
| 15 | righting reflex (GO:0060013) | 3.50629776 |
| 16 | gamma-aminobutyric acid transport (GO:0015812) | 3.40797047 |
| 17 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.40262550 |
| 18 | axon ensheathment in central nervous system (GO:0032291) | 3.39167476 |
| 19 | central nervous system myelination (GO:0022010) | 3.39167476 |
| 20 | head development (GO:0060322) | 3.34670586 |
| 21 | auditory behavior (GO:0031223) | 3.32386574 |
| 22 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.30014531 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 3.29913497 |
| 24 | neuron fate determination (GO:0048664) | 3.29157229 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.23927385 |
| 26 | activated T cell proliferation (GO:0050798) | 3.22887507 |
| 27 | interkinetic nuclear migration (GO:0022027) | 3.14971845 |
| 28 | mechanosensory behavior (GO:0007638) | 3.13901820 |
| 29 | regulation of pigment cell differentiation (GO:0050932) | 3.09863043 |
| 30 | histone H3-K4 trimethylation (GO:0080182) | 3.08587404 |
| 31 | nucleobase catabolic process (GO:0046113) | 3.08091307 |
| 32 | postsynaptic membrane organization (GO:0001941) | 3.07162838 |
| 33 | inner ear receptor cell differentiation (GO:0060113) | 3.05125516 |
| 34 | negative regulation of astrocyte differentiation (GO:0048712) | 3.03772785 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.01730419 |
| 36 | centriole assembly (GO:0098534) | 3.00962627 |
| 37 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00467941 |
| 38 | tongue development (GO:0043586) | 2.99599007 |
| 39 | proline transport (GO:0015824) | 2.97884565 |
| 40 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.93325855 |
| 41 | response to pheromone (GO:0019236) | 2.92671022 |
| 42 | positive regulation of action potential (GO:0045760) | 2.92639664 |
| 43 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.92576804 |
| 44 | cell proliferation in forebrain (GO:0021846) | 2.89486300 |
| 45 | response to auditory stimulus (GO:0010996) | 2.87168968 |
| 46 | lymphoid progenitor cell differentiation (GO:0002320) | 2.84787681 |
| 47 | cyclic nucleotide catabolic process (GO:0009214) | 2.81279348 |
| 48 | neuronal stem cell maintenance (GO:0097150) | 2.76073239 |
| 49 | limb bud formation (GO:0060174) | 2.75326359 |
| 50 | dendritic spine morphogenesis (GO:0060997) | 2.75026108 |
| 51 | reflex (GO:0060004) | 2.74257804 |
| 52 | positive regulation of synapse assembly (GO:0051965) | 2.74179609 |
| 53 | negative regulation of neurotransmitter transport (GO:0051589) | 2.72579396 |
| 54 | regulation of synapse structural plasticity (GO:0051823) | 2.72033285 |
| 55 | neuronal action potential propagation (GO:0019227) | 2.71789337 |
| 56 | calcium ion-dependent exocytosis (GO:0017156) | 2.70626291 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.69997314 |
| 58 | protein polyglutamylation (GO:0018095) | 2.67982305 |
| 59 | neural tube formation (GO:0001841) | 2.67584575 |
| 60 | cilium organization (GO:0044782) | 2.66436419 |
| 61 | intraciliary transport (GO:0042073) | 2.64713125 |
| 62 | protein localization to cilium (GO:0061512) | 2.63750570 |
| 63 | membrane depolarization during action potential (GO:0086010) | 2.62818908 |
| 64 | regulation of platelet aggregation (GO:0090330) | 2.60264635 |
| 65 | glutamate receptor signaling pathway (GO:0007215) | 2.58883621 |
| 66 | regulation of activation of Janus kinase activity (GO:0010533) | 2.58563740 |
| 67 | neuronal action potential (GO:0019228) | 2.57879754 |
| 68 | cilium assembly (GO:0042384) | 2.57571975 |
| 69 | tachykinin receptor signaling pathway (GO:0007217) | 2.57192525 |
| 70 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.56747762 |
| 71 | spinal cord development (GO:0021510) | 2.56199368 |
| 72 | cAMP catabolic process (GO:0006198) | 2.55706772 |
| 73 | mechanoreceptor differentiation (GO:0042490) | 2.55564803 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.54053114 |
| 75 | L-amino acid import (GO:0043092) | 2.53002166 |
| 76 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.52271580 |
| 77 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.52271580 |
| 78 | inner ear receptor stereocilium organization (GO:0060122) | 2.52190458 |
| 79 | piRNA metabolic process (GO:0034587) | 2.50064238 |
| 80 | G-protein coupled receptor internalization (GO:0002031) | 2.48625266 |
| 81 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.47777803 |
| 82 | positive regulation of meiosis (GO:0045836) | 2.47472482 |
| 83 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.46856541 |
| 84 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.46821200 |
| 85 | microtubule bundle formation (GO:0001578) | 2.46026296 |
| 86 | response to epinephrine (GO:0071871) | 2.44895949 |
| 87 | transmission of nerve impulse (GO:0019226) | 2.44541188 |
| 88 | histone H3-K9 methylation (GO:0051567) | 2.43695386 |
| 89 | negative regulation of myoblast differentiation (GO:0045662) | 2.43686019 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 2.43502288 |
| 91 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.43183672 |
| 92 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.42770748 |
| 93 | extracellular regulation of signal transduction (GO:1900115) | 2.42481015 |
| 94 | extracellular negative regulation of signal transduction (GO:1900116) | 2.42481015 |
| 95 | nonmotile primary cilium assembly (GO:0035058) | 2.42468897 |
| 96 | regulation of synapse assembly (GO:0051963) | 2.41644518 |
| 97 | histone H3-K9 modification (GO:0061647) | 2.41424797 |
| 98 | retinal cone cell development (GO:0046549) | 2.41242479 |
| 99 | cell differentiation involved in metanephros development (GO:0072202) | 2.40978756 |
| 100 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.40165557 |
| 101 | photoreceptor cell maintenance (GO:0045494) | 2.39404465 |
| 102 | telencephalon development (GO:0021537) | 2.39335243 |
| 103 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.38588162 |
| 104 | centriole replication (GO:0007099) | 2.37639416 |
| 105 | daunorubicin metabolic process (GO:0044597) | 2.36661554 |
| 106 | polyketide metabolic process (GO:0030638) | 2.36661554 |
| 107 | doxorubicin metabolic process (GO:0044598) | 2.36661554 |
| 108 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.36637963 |
| 109 | retina layer formation (GO:0010842) | 2.36096933 |
| 110 | retinal ganglion cell axon guidance (GO:0031290) | 2.35396471 |
| 111 | otic vesicle formation (GO:0030916) | 2.34514346 |
| 112 | regulation of timing of cell differentiation (GO:0048505) | 2.34307646 |
| 113 | forebrain neuron differentiation (GO:0021879) | 2.33603302 |
| 114 | detection of other organism (GO:0098543) | 2.33373835 |
| 115 | import into cell (GO:0098657) | 2.32719157 |
| 116 | neuron remodeling (GO:0016322) | 2.32635428 |
| 117 | camera-type eye morphogenesis (GO:0048593) | 2.31945632 |
| 118 | synaptic transmission, glutamatergic (GO:0035249) | 2.31915417 |
| 119 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.31816238 |
| 120 | opioid receptor signaling pathway (GO:0038003) | 2.31796055 |
| 121 | serotonin metabolic process (GO:0042428) | 2.31787866 |
| 122 | auditory receptor cell stereocilium organization (GO:0060088) | 2.31657267 |
| 123 | androgen biosynthetic process (GO:0006702) | 2.31199071 |
| 124 | cellular response to epinephrine stimulus (GO:0071872) | 2.30824367 |
| 125 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.30643329 |
| 126 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.30643329 |
| 127 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.30643329 |
| 128 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.30019640 |
| 129 | mitochondrion transport along microtubule (GO:0047497) | 2.29779383 |
| 130 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.29779383 |
| 131 | cell-cell junction maintenance (GO:0045217) | 2.29182145 |
| 132 | cilium morphogenesis (GO:0060271) | 2.28715422 |
| 133 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.28560092 |
| 134 | regulation of male gonad development (GO:2000018) | 2.28270891 |
| 135 | negative regulation of osteoblast proliferation (GO:0033689) | 2.28100029 |
| 136 | adult walking behavior (GO:0007628) | 2.28060017 |
| 137 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.27818034 |
| 138 | retinal rod cell development (GO:0046548) | 2.27751397 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.27576739 |
| 140 | somite development (GO:0061053) | 2.27569827 |
| 141 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.26990648 |
| 142 | cranial nerve structural organization (GO:0021604) | 2.26967523 |
| 143 | GPI anchor metabolic process (GO:0006505) | 2.26691496 |
| 144 | developmental pigmentation (GO:0048066) | 2.26166772 |
| 145 | eye photoreceptor cell differentiation (GO:0001754) | 2.25813342 |
| 146 | photoreceptor cell differentiation (GO:0046530) | 2.25813342 |
| 147 | synapse assembly (GO:0007416) | 2.25394132 |
| 148 | negative regulation of stem cell proliferation (GO:2000647) | 2.25382675 |
| 149 | cell differentiation in hindbrain (GO:0021533) | 2.24905563 |
| 150 | mature B cell differentiation (GO:0002335) | 2.24312862 |
| 151 | positive regulation of meiotic cell cycle (GO:0051446) | 2.23366565 |
| 152 | establishment of protein localization to Golgi (GO:0072600) | 2.23012282 |
| 153 | GPI anchor biosynthetic process (GO:0006506) | 2.22909327 |
| 154 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.22312634 |
| 155 | dendritic cell chemotaxis (GO:0002407) | 2.22178369 |
| 156 | neuron-neuron synaptic transmission (GO:0007270) | 2.22153164 |
| 157 | energy homeostasis (GO:0097009) | 2.21439380 |
| 158 | regulation of neurotransmitter uptake (GO:0051580) | 2.21098085 |
| 159 | detection of bacterium (GO:0016045) | 2.20567521 |
| 160 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.20452939 |
| 161 | mannosylation (GO:0097502) | 2.19113568 |
| 162 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.18897134 |
| 163 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.17546390 |
| 164 | response to redox state (GO:0051775) | 2.17415658 |
| 165 | behavioral response to nicotine (GO:0035095) | 2.16085884 |
| 166 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.15829925 |
| 167 | cell differentiation involved in kidney development (GO:0061005) | 2.15222520 |
| 168 | cranial nerve morphogenesis (GO:0021602) | 2.15075568 |
| 169 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.14980604 |
| 170 | detection of light stimulus involved in visual perception (GO:0050908) | 2.14980604 |
| 171 | protein localization to synapse (GO:0035418) | 2.14713069 |
| 172 | DNA integration (GO:0015074) | 2.13812774 |
| 173 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.13601474 |
| 174 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.13023615 |
| 175 | glycerophospholipid catabolic process (GO:0046475) | 2.12950476 |
| 176 | serotonin receptor signaling pathway (GO:0007210) | 2.12926863 |
| 177 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.12728409 |
| 178 | neurotransmitter uptake (GO:0001504) | 2.12216291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.15666632 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16239528 |
| 3 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.89800138 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.51226140 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.47274178 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.37691008 |
| 7 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.36544182 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29964699 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.25304799 |
| 10 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.25289602 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.22251680 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.15865427 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.13208130 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10028174 |
| 15 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.07564046 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05200249 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03964007 |
| 18 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.98994042 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96698349 |
| 20 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.96375887 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95605638 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91676467 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90210126 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.88950934 |
| 25 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.86792964 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81817831 |
| 27 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.80529165 |
| 28 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.80124917 |
| 29 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.78528366 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78238648 |
| 31 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.77983980 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76918404 |
| 33 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.73708871 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72939249 |
| 35 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.72850841 |
| 36 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.72419379 |
| 37 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.71300769 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.69862947 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69778775 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69335099 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.68307457 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68261846 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68261846 |
| 44 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.65836844 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62626979 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62430412 |
| 47 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.61079379 |
| 48 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.60214671 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59437318 |
| 50 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.57638583 |
| 51 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.57217845 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56484635 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56289074 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55190187 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53561253 |
| 56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52876284 |
| 57 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52511674 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51895712 |
| 59 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.51735061 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.50674258 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49739888 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49141525 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48614105 |
| 64 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.46739250 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45251974 |
| 66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.44975217 |
| 67 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.44183955 |
| 68 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.43560338 |
| 69 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.43474658 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40658192 |
| 71 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40278916 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.39611615 |
| 73 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38597084 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38011642 |
| 75 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.37930063 |
| 76 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.37322257 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36667746 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35214799 |
| 79 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.34624691 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34619868 |
| 81 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.34441476 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.34319840 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32781656 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32439157 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32166760 |
| 86 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.30793297 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30649597 |
| 88 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28545480 |
| 89 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.28089766 |
| 90 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.27669748 |
| 91 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25934378 |
| 92 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25459056 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24659086 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24210178 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24122907 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22033262 |
| 97 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21727980 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21688742 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21688742 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20981472 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20950941 |
| 102 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20715675 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20715675 |
| 104 | KDM2B_26808549_Chip-Seq_REH_Human | 1.18495352 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18169282 |
| 106 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18000916 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16701255 |
| 108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15343397 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15241812 |
| 110 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.14745279 |
| 111 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.14629453 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13354057 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12975477 |
| 114 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12970884 |
| 115 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12859750 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12830750 |
| 117 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.12631612 |
| 118 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12331635 |
| 119 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07216344 |
| 120 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06772297 |
| 121 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05426089 |
| 122 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02792119 |
| 123 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02146238 |
| 124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00739977 |
| 125 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99823810 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99449787 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98759269 |
| 128 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96383662 |
| 129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95117807 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93637261 |
| 131 | AR_19668381_ChIP-Seq_PC3_Human | 0.93302378 |
| 132 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92278732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001188_hyperpigmentation | 4.06514106 |
| 2 | MP0003880_abnormal_central_pattern | 3.28105372 |
| 3 | MP0004885_abnormal_endolymph | 3.03490222 |
| 4 | MP0006292_abnormal_olfactory_placode | 2.93840004 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 2.66283126 |
| 6 | MP0005409_darkened_coat_color | 2.59976684 |
| 7 | MP0003787_abnormal_imprinting | 2.59372523 |
| 8 | MP0003136_yellow_coat_color | 2.58538613 |
| 9 | MP0001486_abnormal_startle_reflex | 2.43679214 |
| 10 | MP0005171_absent_coat_pigmentation | 2.43537436 |
| 11 | MP0005646_abnormal_pituitary_gland | 2.43406426 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.31127022 |
| 13 | MP0002102_abnormal_ear_morphology | 2.20521477 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.10977958 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.08688576 |
| 16 | MP0009745_abnormal_behavioral_response | 2.02253072 |
| 17 | MP0004742_abnormal_vestibular_system | 2.01061650 |
| 18 | MP0000566_synostosis | 2.00714029 |
| 19 | MP0002736_abnormal_nociception_after | 1.96931085 |
| 20 | MP0005423_abnormal_somatic_nervous | 1.96560423 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.95436764 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.88757252 |
| 23 | MP0004133_heterotaxia | 1.86016204 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.82963910 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.81218131 |
| 26 | MP0009046_muscle_twitch | 1.80567650 |
| 27 | MP0001905_abnormal_dopamine_level | 1.78755270 |
| 28 | MP0004142_abnormal_muscle_tone | 1.76254773 |
| 29 | MP0002272_abnormal_nervous_system | 1.75064529 |
| 30 | MP0001529_abnormal_vocalization | 1.65515817 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.64012850 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.63516629 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.63496576 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.62284098 |
| 35 | MP0002064_seizures | 1.57533614 |
| 36 | MP0004043_abnormal_pH_regulation | 1.53538127 |
| 37 | MP0008260_abnormal_autophagy | 1.52394599 |
| 38 | MP0003635_abnormal_synaptic_transmissio | 1.50585599 |
| 39 | MP0000015_abnormal_ear_pigmentation | 1.50127948 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.47186404 |
| 41 | MP0001963_abnormal_hearing_physiology | 1.45015859 |
| 42 | MP0000026_abnormal_inner_ear | 1.44572257 |
| 43 | MP0004381_abnormal_hair_follicle | 1.44438154 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 1.43374248 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.41485747 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.41431321 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.39047414 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.37739259 |
| 49 | MP0003195_calcinosis | 1.35862032 |
| 50 | MP0005379_endocrine/exocrine_gland_phen | 1.35410947 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.32780076 |
| 52 | MP0008789_abnormal_olfactory_epithelium | 1.32086971 |
| 53 | MP0002063_abnormal_learning/memory/cond | 1.30898128 |
| 54 | MP0000955_abnormal_spinal_cord | 1.30702619 |
| 55 | MP0003283_abnormal_digestive_organ | 1.30637782 |
| 56 | MP0009697_abnormal_copulation | 1.28332535 |
| 57 | MP0005394_taste/olfaction_phenotype | 1.28142098 |
| 58 | MP0005499_abnormal_olfactory_system | 1.28142098 |
| 59 | MP0002928_abnormal_bile_duct | 1.27907779 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.27726352 |
| 61 | MP0000920_abnormal_myelination | 1.23703019 |
| 62 | MP0000778_abnormal_nervous_system | 1.22391287 |
| 63 | MP0008877_abnormal_DNA_methylation | 1.22376244 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.21419733 |
| 65 | MP0001346_abnormal_lacrimal_gland | 1.20574421 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.20533693 |
| 67 | MP0001984_abnormal_olfaction | 1.19777646 |
| 68 | MP0003122_maternal_imprinting | 1.15685931 |
| 69 | MP0003878_abnormal_ear_physiology | 1.15361883 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.15361883 |
| 71 | MP0004130_abnormal_muscle_cell | 1.11749992 |
| 72 | MP0008995_early_reproductive_senescence | 1.11442829 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.08813327 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.08721723 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.07665564 |
| 76 | MP0002163_abnormal_gland_morphology | 1.07534343 |
| 77 | MP0008004_abnormal_stomach_pH | 1.06768458 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.02003836 |
| 79 | MP0004924_abnormal_behavior | 1.00740716 |
| 80 | MP0005386_behavior/neurological_phenoty | 1.00740716 |
| 81 | MP0001970_abnormal_pain_threshold | 1.00724061 |
| 82 | MP0003724_increased_susceptibility_to | 1.00284586 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.99984608 |
| 84 | MP0002938_white_spotting | 0.97583615 |
| 85 | MP0005195_abnormal_posterior_eye | 0.96241295 |
| 86 | MP0005253_abnormal_eye_physiology | 0.92958331 |
| 87 | MP0004270_analgesia | 0.92689851 |
| 88 | MP0003879_abnormal_hair_cell | 0.92376569 |
| 89 | MP0002249_abnormal_larynx_morphology | 0.91175302 |
| 90 | MP0002752_abnormal_somatic_nervous | 0.89784700 |
| 91 | MP0002751_abnormal_autonomic_nervous | 0.89634002 |
| 92 | MP0002152_abnormal_brain_morphology | 0.88797588 |
| 93 | MP0000681_abnormal_thyroid_gland | 0.88353236 |
| 94 | MP0009379_abnormal_foot_pigmentation | 0.87350656 |
| 95 | MP0002184_abnormal_innervation | 0.85738568 |
| 96 | MP0009785_altered_susceptibility_to | 0.84265182 |
| 97 | MP0001835_abnormal_antigen_presentation | 0.83830666 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.83421334 |
| 99 | MP0005671_abnormal_response_to | 0.82279317 |
| 100 | MP0008872_abnormal_physiological_respon | 0.81882247 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.81320676 |
| 102 | MP0004484_altered_response_of | 0.80847550 |
| 103 | MP0005310_abnormal_salivary_gland | 0.80454255 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.77570359 |
| 105 | MP0002733_abnormal_thermal_nociception | 0.76770778 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.76360183 |
| 107 | MP0003690_abnormal_glial_cell | 0.75857102 |
| 108 | MP0001664_abnormal_digestion | 0.75769163 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75696276 |
| 110 | MP0003633_abnormal_nervous_system | 0.75468219 |
| 111 | MP0002882_abnormal_neuron_morphology | 0.74964295 |
| 112 | MP0003121_genomic_imprinting | 0.73404465 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.73328332 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.72074646 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.70927664 |
| 116 | MP0008569_lethality_at_weaning | 0.70736932 |
| 117 | MP0002822_catalepsy | 0.70535411 |
| 118 | MP0001293_anophthalmia | 0.70524230 |
| 119 | MP0004811_abnormal_neuron_physiology | 0.69723894 |
| 120 | MP0000049_abnormal_middle_ear | 0.69354509 |
| 121 | MP0002229_neurodegeneration | 0.68544022 |
| 122 | MP0000427_abnormal_hair_cycle | 0.68513689 |
| 123 | MP0002066_abnormal_motor_capabilities/c | 0.67415438 |
| 124 | MP0001790_abnormal_immune_system | 0.66894237 |
| 125 | MP0005387_immune_system_phenotype | 0.66894237 |
| 126 | MP0003938_abnormal_ear_development | 0.66301086 |
| 127 | MP0002132_abnormal_respiratory_system | 0.65553951 |
| 128 | MP0009250_abnormal_appendicular_skeleto | 0.65255324 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.64412927 |
| 130 | MP0005448_abnormal_energy_balance | 0.63502385 |
| 131 | MP0001177_atelectasis | 0.62246524 |
| 132 | MP0003698_abnormal_male_reproductive | 0.60476124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Febrile seizures (HP:0002373) | 4.31803746 |
| 2 | Abnormality of midbrain morphology (HP:0002418) | 3.98416675 |
| 3 | Molar tooth sign on MRI (HP:0002419) | 3.98416675 |
| 4 | Pancreatic cysts (HP:0001737) | 3.69951097 |
| 5 | Papilledema (HP:0001085) | 3.63239849 |
| 6 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.47040584 |
| 7 | Focal motor seizures (HP:0011153) | 3.39724260 |
| 8 | Septo-optic dysplasia (HP:0100842) | 3.19572192 |
| 9 | Hypothermia (HP:0002045) | 3.09826336 |
| 10 | Abnormal ciliary motility (HP:0012262) | 3.02571248 |
| 11 | Congenital sensorineural hearing impairment (HP:0008527) | 3.00091883 |
| 12 | Oligodactyly (hands) (HP:0001180) | 2.99315613 |
| 13 | Chromsome breakage (HP:0040012) | 2.96803702 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 2.95227841 |
| 15 | Abnormal hair whorl (HP:0010721) | 2.89878922 |
| 16 | Patchy hypopigmentation of hair (HP:0011365) | 2.87172513 |
| 17 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.83200499 |
| 18 | Absent/shortened dynein arms (HP:0200106) | 2.83200499 |
| 19 | Volvulus (HP:0002580) | 2.81500038 |
| 20 | White forelock (HP:0002211) | 2.80819751 |
| 21 | Epileptic encephalopathy (HP:0200134) | 2.76401332 |
| 22 | Cystic liver disease (HP:0006706) | 2.75270203 |
| 23 | Duplicated collecting system (HP:0000081) | 2.70719323 |
| 24 | True hermaphroditism (HP:0010459) | 2.69641389 |
| 25 | Decreased central vision (HP:0007663) | 2.68932963 |
| 26 | Protruding tongue (HP:0010808) | 2.65804484 |
| 27 | Abnormality of the renal collecting system (HP:0004742) | 2.62362382 |
| 28 | Tubulointerstitial nephritis (HP:0001970) | 2.61109957 |
| 29 | Nephronophthisis (HP:0000090) | 2.59447052 |
| 30 | Optic nerve hypoplasia (HP:0000609) | 2.58872308 |
| 31 | Fair hair (HP:0002286) | 2.55185539 |
| 32 | Genetic anticipation (HP:0003743) | 2.55105316 |
| 33 | Decreased circulating renin level (HP:0003351) | 2.51346645 |
| 34 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.50454072 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.48924634 |
| 36 | Medial flaring of the eyebrow (HP:0010747) | 2.48148532 |
| 37 | Anomalous pulmonary venous return (HP:0010772) | 2.47953688 |
| 38 | Abnormality of incisor morphology (HP:0011063) | 2.44391499 |
| 39 | Rhinitis (HP:0012384) | 2.40630087 |
| 40 | Truncal obesity (HP:0001956) | 2.37904838 |
| 41 | Congenital stationary night blindness (HP:0007642) | 2.36733923 |
| 42 | Chronic hepatic failure (HP:0100626) | 2.36195723 |
| 43 | Oligodactyly (HP:0012165) | 2.36047731 |
| 44 | Widely spaced teeth (HP:0000687) | 2.34927449 |
| 45 | Absent septum pellucidum (HP:0001331) | 2.34094538 |
| 46 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.32993744 |
| 47 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.32993744 |
| 48 | Hemiparesis (HP:0001269) | 2.31394712 |
| 49 | Absent speech (HP:0001344) | 2.30843531 |
| 50 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.29926129 |
| 51 | Abnormality of the pubic bones (HP:0003172) | 2.29881973 |
| 52 | Abnormal drinking behavior (HP:0030082) | 2.28638522 |
| 53 | Polydipsia (HP:0001959) | 2.28638522 |
| 54 | Renal cortical cysts (HP:0000803) | 2.26841133 |
| 55 | Aplasia cutis congenita (HP:0001057) | 2.23335130 |
| 56 | Type II lissencephaly (HP:0007260) | 2.22843730 |
| 57 | Tented upper lip vermilion (HP:0010804) | 2.21711086 |
| 58 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.19967213 |
| 59 | Hypoplasia of the fovea (HP:0007750) | 2.19967213 |
| 60 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17997594 |
| 61 | Bronchiectasis (HP:0002110) | 2.17417760 |
| 62 | Keratoconus (HP:0000563) | 2.15389517 |
| 63 | Increased corneal curvature (HP:0100692) | 2.15389517 |
| 64 | Generalized hypopigmentation of hair (HP:0011358) | 2.14917632 |
| 65 | Gaze-evoked nystagmus (HP:0000640) | 2.14332253 |
| 66 | Abnormality of the pulmonary veins (HP:0011718) | 2.14118118 |
| 67 | Focal seizures (HP:0007359) | 2.13985269 |
| 68 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.13227432 |
| 69 | Blue irides (HP:0000635) | 2.10927118 |
| 70 | Gait imbalance (HP:0002141) | 2.10770780 |
| 71 | Neuroendocrine neoplasm (HP:0100634) | 2.10453532 |
| 72 | Pancreatic fibrosis (HP:0100732) | 2.08298497 |
| 73 | Congenital primary aphakia (HP:0007707) | 2.07313154 |
| 74 | Abnormality of the septum pellucidum (HP:0007375) | 2.06967353 |
| 75 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.06828109 |
| 76 | Male pseudohermaphroditism (HP:0000037) | 2.06540266 |
| 77 | Renal Fanconi syndrome (HP:0001994) | 2.05436051 |
| 78 | Postaxial foot polydactyly (HP:0001830) | 2.04870442 |
| 79 | Osteomalacia (HP:0002749) | 2.04126115 |
| 80 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.03884076 |
| 81 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.03884076 |
| 82 | Abnormality of the aortic arch (HP:0012303) | 2.03076852 |
| 83 | Type I transferrin isoform profile (HP:0003642) | 2.02954881 |
| 84 | Hyperventilation (HP:0002883) | 2.01753877 |
| 85 | Abnormality of DNA repair (HP:0003254) | 2.01521555 |
| 86 | Prostate neoplasm (HP:0100787) | 2.01474087 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.01126070 |
| 88 | Progressive inability to walk (HP:0002505) | 2.01081898 |
| 89 | Large for gestational age (HP:0001520) | 2.00534461 |
| 90 | Abnormality of macular pigmentation (HP:0008002) | 1.99439891 |
| 91 | Asplenia (HP:0001746) | 1.98138120 |
| 92 | Severe visual impairment (HP:0001141) | 1.96748844 |
| 93 | Retinitis pigmentosa (HP:0000510) | 1.95916931 |
| 94 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.95650482 |
| 95 | Abnormal eating behavior (HP:0100738) | 1.95633763 |
| 96 | Postaxial hand polydactyly (HP:0001162) | 1.95449524 |
| 97 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.94443933 |
| 98 | Polyphagia (HP:0002591) | 1.93957724 |
| 99 | Hemiplegia (HP:0002301) | 1.93603068 |
| 100 | Parakeratosis (HP:0001036) | 1.93020885 |
| 101 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92119370 |
| 102 | Hypoplastic ischia (HP:0003175) | 1.91732988 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91515624 |
| 104 | Inability to walk (HP:0002540) | 1.91347483 |
| 105 | Sclerocornea (HP:0000647) | 1.89763766 |
| 106 | Tubular atrophy (HP:0000092) | 1.89663318 |
| 107 | Stomach cancer (HP:0012126) | 1.89209494 |
| 108 | Hypoplastic left heart (HP:0004383) | 1.88851400 |
| 109 | Nonprogressive disorder (HP:0003680) | 1.88427433 |
| 110 | Drooling (HP:0002307) | 1.87404723 |
| 111 | Retrobulbar optic neuritis (HP:0100654) | 1.86616685 |
| 112 | Optic neuritis (HP:0100653) | 1.86616685 |
| 113 | Abnormality of renal resorption (HP:0011038) | 1.86510160 |
| 114 | Intestinal atresia (HP:0011100) | 1.85996467 |
| 115 | Abnormality of the ischium (HP:0003174) | 1.85709002 |
| 116 | Fetal akinesia sequence (HP:0001989) | 1.85506932 |
| 117 | Abnormality of the fovea (HP:0000493) | 1.85152314 |
| 118 | Occipital encephalocele (HP:0002085) | 1.84564123 |
| 119 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.84553142 |
| 120 | Alveolar cell carcinoma (HP:0006519) | 1.84126480 |
| 121 | Anophthalmia (HP:0000528) | 1.84061004 |
| 122 | Conical tooth (HP:0000698) | 1.83858653 |
| 123 | Hypoplastic heart (HP:0001961) | 1.83551965 |
| 124 | Thyroid-stimulating hormone excess (HP:0002925) | 1.83373229 |
| 125 | Agitation (HP:0000713) | 1.83200753 |
| 126 | Cerebellar dysplasia (HP:0007033) | 1.83045177 |
| 127 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.81964638 |
| 128 | Narrow forehead (HP:0000341) | 1.81287515 |
| 129 | Bilateral microphthalmos (HP:0007633) | 1.81125141 |
| 130 | Broad-based gait (HP:0002136) | 1.79898208 |
| 131 | Congenital hepatic fibrosis (HP:0002612) | 1.79640914 |
| 132 | Excessive salivation (HP:0003781) | 1.79264284 |
| 133 | Upper limb muscle weakness (HP:0003484) | 1.78487993 |
| 134 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78110369 |
| 135 | Poor coordination (HP:0002370) | 1.77687252 |
| 136 | Pachygyria (HP:0001302) | 1.77460081 |
| 137 | Genital tract atresia (HP:0001827) | 1.77191197 |
| 138 | Myokymia (HP:0002411) | 1.76684751 |
| 139 | Attenuation of retinal blood vessels (HP:0007843) | 1.75932191 |
| 140 | Recurrent pneumonia (HP:0006532) | 1.75727970 |
| 141 | Abnormality of the nasal septum (HP:0000419) | 1.75227706 |
| 142 | Anencephaly (HP:0002323) | 1.74894315 |
| 143 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.74073704 |
| 144 | 3-Methylglutaconic aciduria (HP:0003535) | 1.73751309 |
| 145 | Vaginal atresia (HP:0000148) | 1.73446481 |
| 146 | Duplication of thumb phalanx (HP:0009942) | 1.73303188 |
| 147 | Polyuria (HP:0000103) | 1.73083530 |
| 148 | Agammaglobulinemia (HP:0004432) | 1.73082705 |
| 149 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.72569933 |
| 150 | Recurrent cutaneous fungal infections (HP:0011370) | 1.72569933 |
| 151 | Increased IgM level (HP:0003496) | 1.72346831 |
| 152 | Abnormality of the renal cortex (HP:0011035) | 1.71542342 |
| 153 | Hypoplastic iliac wings (HP:0002866) | 1.71015629 |
| 154 | Atonic seizures (HP:0010819) | 1.70933474 |
| 155 | Abolished electroretinogram (ERG) (HP:0000550) | 1.70757292 |
| 156 | Short tibia (HP:0005736) | 1.70685822 |
| 157 | Cutaneous finger syndactyly (HP:0010554) | 1.69959209 |
| 158 | Submucous cleft hard palate (HP:0000176) | 1.69513505 |
| 159 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.67535568 |
| 160 | Median cleft lip (HP:0000161) | 1.67365400 |
| 161 | Prolonged bleeding time (HP:0003010) | 1.66880655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.85888256 |
| 2 | TNIK | 3.62722814 |
| 3 | PRKD3 | 2.74169993 |
| 4 | STK16 | 2.72479461 |
| 5 | PRPF4B | 2.37631920 |
| 6 | MAP2K7 | 2.33070866 |
| 7 | PNCK | 2.20534827 |
| 8 | TXK | 2.12758952 |
| 9 | MAP4K2 | 2.08746606 |
| 10 | ZAK | 2.05755095 |
| 11 | NEK6 | 2.02813654 |
| 12 | SIK3 | 2.01635390 |
| 13 | MAP3K14 | 1.97867695 |
| 14 | ADRBK2 | 1.92052817 |
| 15 | NUAK1 | 1.85065763 |
| 16 | EIF2AK2 | 1.80020111 |
| 17 | GRK7 | 1.77847796 |
| 18 | IRAK3 | 1.73023434 |
| 19 | MUSK | 1.73007529 |
| 20 | IRAK4 | 1.72592302 |
| 21 | INSRR | 1.72374940 |
| 22 | YES1 | 1.71957709 |
| 23 | MAPK13 | 1.66995299 |
| 24 | NTRK3 | 1.65523887 |
| 25 | BMPR2 | 1.59489651 |
| 26 | OXSR1 | 1.59063989 |
| 27 | MKNK2 | 1.57479598 |
| 28 | DAPK2 | 1.57200451 |
| 29 | GRK1 | 1.53623316 |
| 30 | STK39 | 1.47923636 |
| 31 | NEK2 | 1.44433122 |
| 32 | MAP3K13 | 1.42101366 |
| 33 | WNK4 | 1.40625063 |
| 34 | PKN1 | 1.27685067 |
| 35 | BMPR1B | 1.26935170 |
| 36 | SGK2 | 1.20079005 |
| 37 | MKNK1 | 1.19688873 |
| 38 | BCR | 1.19639472 |
| 39 | TEC | 1.17278839 |
| 40 | AKT3 | 1.16071985 |
| 41 | CLK1 | 1.15827353 |
| 42 | TNK2 | 1.14153296 |
| 43 | CDK3 | 1.12740875 |
| 44 | MAP3K7 | 1.04786881 |
| 45 | SGK223 | 1.04213617 |
| 46 | SGK494 | 1.04213617 |
| 47 | MARK2 | 1.03373147 |
| 48 | VRK1 | 1.02748546 |
| 49 | PAK3 | 1.00289981 |
| 50 | PRKCE | 0.99167412 |
| 51 | PIK3CA | 0.98485202 |
| 52 | CAMKK1 | 0.98130398 |
| 53 | RIPK4 | 0.94334280 |
| 54 | IRAK1 | 0.94326229 |
| 55 | IRAK2 | 0.93144502 |
| 56 | SRPK1 | 0.91551125 |
| 57 | CAMKK2 | 0.90120022 |
| 58 | PIK3CG | 0.89040177 |
| 59 | STK11 | 0.88792481 |
| 60 | CDK8 | 0.86927395 |
| 61 | EPHA4 | 0.86874106 |
| 62 | TYRO3 | 0.86581245 |
| 63 | STK38 | 0.85041135 |
| 64 | EIF2AK3 | 0.83901090 |
| 65 | FES | 0.83569151 |
| 66 | PRKCH | 0.82989486 |
| 67 | PLK2 | 0.80930268 |
| 68 | PRKD2 | 0.80063339 |
| 69 | TIE1 | 0.78244760 |
| 70 | MAP3K12 | 0.77814120 |
| 71 | IKBKE | 0.76812487 |
| 72 | PBK | 0.75001095 |
| 73 | MAP4K1 | 0.73964455 |
| 74 | FGFR2 | 0.72885881 |
| 75 | MAP2K4 | 0.71183111 |
| 76 | ACVR1B | 0.71103516 |
| 77 | PINK1 | 0.70185889 |
| 78 | MAPKAPK5 | 0.69917420 |
| 79 | IKBKB | 0.68288744 |
| 80 | CAMK2B | 0.67807792 |
| 81 | MARK1 | 0.67328234 |
| 82 | PTK2B | 0.65669441 |
| 83 | STK38L | 0.65408649 |
| 84 | EPHA3 | 0.65364262 |
| 85 | TAOK3 | 0.64587733 |
| 86 | CAMK2A | 0.63843794 |
| 87 | NLK | 0.63038007 |
| 88 | PRKG1 | 0.60670722 |
| 89 | TLK1 | 0.58167878 |
| 90 | NTRK2 | 0.57660205 |
| 91 | MAPK15 | 0.55979522 |
| 92 | CAMK1G | 0.55935937 |
| 93 | BLK | 0.54908868 |
| 94 | MARK3 | 0.53441230 |
| 95 | ERBB3 | 0.53384580 |
| 96 | SIK2 | 0.52809841 |
| 97 | CDK5 | 0.52440478 |
| 98 | SGK1 | 0.51655885 |
| 99 | CAMK2D | 0.50644464 |
| 100 | BTK | 0.50535049 |
| 101 | LYN | 0.50099242 |
| 102 | FRK | 0.49805475 |
| 103 | PAK6 | 0.49615182 |
| 104 | DYRK1B | 0.48903136 |
| 105 | ERBB2 | 0.48483019 |
| 106 | PRKCQ | 0.48481163 |
| 107 | WNK3 | 0.48438102 |
| 108 | OBSCN | 0.48314557 |
| 109 | STK24 | 0.47290233 |
| 110 | PHKG2 | 0.47095061 |
| 111 | PHKG1 | 0.47095061 |
| 112 | ITK | 0.46354108 |
| 113 | NME1 | 0.45347082 |
| 114 | EPHB2 | 0.45071322 |
| 115 | HIPK2 | 0.45041847 |
| 116 | KIT | 0.44786300 |
| 117 | CDK19 | 0.44106491 |
| 118 | CAMK4 | 0.44057946 |
| 119 | MAPK7 | 0.43979026 |
| 120 | UHMK1 | 0.43648472 |
| 121 | FLT3 | 0.43561523 |
| 122 | CSNK1A1L | 0.43308033 |
| 123 | WNK1 | 0.41683788 |
| 124 | DMPK | 0.40730233 |
| 125 | TGFBR1 | 0.40453246 |
| 126 | TRPM7 | 0.39804030 |
| 127 | DYRK1A | 0.39677192 |
| 128 | CAMK1 | 0.38406107 |
| 129 | SYK | 0.37648037 |
| 130 | PRKACA | 0.37548646 |
| 131 | CSNK1G1 | 0.37481095 |
| 132 | ADRBK1 | 0.37436400 |
| 133 | SGK3 | 0.37169951 |
| 134 | CSNK1G3 | 0.37123443 |
| 135 | PRKCG | 0.36838954 |
| 136 | MST4 | 0.36515204 |
| 137 | DYRK2 | 0.36055598 |
| 138 | RPS6KA5 | 0.36037126 |
| 139 | PRKCZ | 0.35627793 |
| 140 | MAP3K4 | 0.35351708 |
| 141 | PRKAA2 | 0.32041283 |
| 142 | MAP2K2 | 0.31785616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.41846157 |
| 2 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.45185383 |
| 3 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.28173999 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.26481058 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.07710572 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06261625 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 1.98622555 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.96997857 |
| 9 | Taste transduction_Homo sapiens_hsa04742 | 1.89789216 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.89578025 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84418780 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82756836 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.81841090 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71413883 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.70285946 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.63442252 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59366947 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.53453451 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52147711 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51993054 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49596204 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49350209 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48110695 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.47006918 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.43496239 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.41861492 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.41306401 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39392909 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.38856501 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32778587 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32001835 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30161217 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.27344351 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.24360319 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24101629 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23692247 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23088423 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22896101 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20843047 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20493530 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20096519 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19151583 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.10291946 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09341344 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07854611 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07435320 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.07292027 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.05076792 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03430966 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03254411 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01746687 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99183476 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98507119 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 0.97669370 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97051299 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.95305304 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.95134862 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.92017467 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91420836 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90163893 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89137343 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.88771202 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88158709 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.88089313 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.87520186 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84523377 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83711793 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83684110 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.82369176 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.81382438 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81339674 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81104330 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80238391 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80221862 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78611322 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.77711297 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.76329878 |
| 78 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76289723 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75520734 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.75400158 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74367588 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72477908 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72290002 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70959229 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70951858 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70644307 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.69993739 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69022478 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67245032 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65946485 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65541533 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64148589 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.63826008 |
| 94 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63315140 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63060376 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62175351 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62034650 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60671192 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.60658570 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60285293 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59907556 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59774120 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59270671 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.58131282 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57713566 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57308479 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56867842 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.56677995 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.55470719 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55000325 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53688757 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52249950 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51719243 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51618527 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51463160 |
| 116 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51406513 |
| 117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51162498 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50324317 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.49781501 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48594084 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48022252 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47773561 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47245362 |
| 124 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47235050 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46876717 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46739129 |
| 127 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46145168 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45642825 |
| 129 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45107490 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43081940 |
| 131 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43008581 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43004211 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42200121 |
| 134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40435622 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40417259 |
| 136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40084258 |
| 137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39611236 |
| 138 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38527508 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37894644 |
| 140 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37548458 |
| 141 | Purine metabolism_Homo sapiens_hsa00230 | 0.37545636 |

